Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
The company manufactures and exports diagnostic instruments and reagents for the prevention, early detection, diagnosis, and monitoring of diseases.
Transasia Bio-Medicals Limited, is an unlisted public company incorporated on 10 May, 1985. It is classified as a public limited company and is located in Mumbai, Maharashtra. It's authorized share capital is INR 4.40 cr and the total paid-up capital is INR 4.00 cr.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2022 numbers.
38.02%
41.32%
362.81%
-9.9%
-97.19%
-6.18%
-2.44
0.74
18.17
12.55
22.21
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(21)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
HDFC Bank Limited
No. of Loans: 1
Total Amount : 42.0 cr
CitiBank N.A.
No. of Loans: 1
Total Amount : 30.0 cr
The Hongkong and Shanghai Banking Corporation Limited
No. of Loans: 1
Total Amount : 20.0 cr
The Royal Bank of Scotland N V
No. of Loans: 1
Total Amount : 16.0 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Vivek Gul Asrani | 00114447 | 10 years |
| Director | Suresh Hassanand Vazirani
Shareholder
|
00122486 | 17 years |
| Director | Mala Suresh Vazirani
Shareholder
|
00122711 | 14 years |
| Director | Shiraz Bugwadia Homi | 01213884 | 4 years |
| Director | Nishant Saxena | 01740242 | 1 years |
| Director | Sunil Hassanand Vazirani | 01995629 | 1 years |
| Director | Nikhil Kumar Suresh Vazirani
Shareholder
|
03008932 | 4 years |
| Kmp | Ashok Kanwarlal Suthar | <HIDDEN> | 1 years |
| Whole-time Director | Vibhuti Krish Raveshia
Shareholder
|
07229727 | 3 years |
| Kmp | Aravind Viswanathan | <HIDDEN> | 1 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| SHREE LUXMI WOOLLEN MILLS ESTATE LIMITED |
Active
|
5.0 L | 1 | Maharashtra |
| INDO-ITALIAN FURNITURE COMPANY PRIVATE LIMITED |
Active
|
1.4 Cr | 1 | Maharashtra |
| GRP LIMITED |
Active
|
5.3 Cr | 1 | Gujarat |
| ZESA PROPERTIES PRIVATE LIMITED |
Active
|
9.0 L | 1 | Maharashtra |
| OM PHARMACEUTICALS LIMITED |
Active
|
9.2 L | 1 | Maharashtra |
| CARTRADE TECH LIMITED |
Active
|
47.3 Cr | 1 | Maharashtra |
| VAZIRANI PROPERTIES PRIVATE LIMITED |
Active
|
1.0 Cr | 4 | Maharashtra |
| VAZIRANI FOUNDATION |
Active
|
1.0 L | 4 | Maharashtra |
| TAIPAN SEA FOODS LIMITED |
Active
|
5.0 L | 2 | Maharashtra |
| TRANSASIA INSTRUMENTS LIMITED |
Active
|
5.0 L | 2 | Maharashtra |
| TRANSASIA DIAGNOSTICS SOLUTIONS LIMITED |
Active
|
5.0 L | 4 | Maharashtra |
| SYSMEX TRANSASIA SERVICES PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| VAZIRANI REALTY PRIVATE LIMITED |
Active
|
10.0 L | 3 | Maharashtra |
| TRANSASIA DIAGNOSTICS PRIVATE LIMITED |
Active
|
25.0 Cr | 5 | Maharashtra |
| O3 FINANCE PRIVATE LIMITED |
Active
|
3.8 Cr | 1 | Karnataka |
| O3 BHUVI ADVISORS PRIVATE LIMITED |
Active
|
3.0 Cr | 1 | Karnataka |
| OSGTHREE ADVISORS PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | West Bengal |
| O3 ALTERNATIVES PRIVATE LIMITED |
Active
|
3.3 Cr | 1 | Karnataka |
| PROTEUS MEDIA AGGREGATOR PRIVATE LIMITED |
Strike Off
|
0.0 | 1 | Maharashtra |
| SANKHYA CAPITAL ADVISORS PRIVATE LIMITED |
Strike Off
|
0.0 | 1 | Maharashtra |
| SRA MERCHANDISE PRIVATE LIMITED |
Amalgamated
|
38.8 L | 1 | West Bengal |
| CREDIT ALTS PRIVATE LIMITED |
Strike Off
|
1.5 L | 1 | Karnataka |
| OGANESSON CAPITAL ADVISORS PRIVATE LIMITED |
Active
|
30,000.0 | 1 | Karnataka |
| DUI INVESTMENT ADVISORS LLP |
Active
|
217.3 Cr | 1 | Maharashtra |
| FLINT MANAGEMENT CONSULTANTS LLP |
Active
|
14.2 Cr | 1 | Maharashtra |
| Jyeshtha Consultancy LLP |
Active
|
10,000.0 | 1 | Karnataka |
| AEK MANAGEMENT CONSULTING LLP |
Active
|
133.7 Cr | 1 | West Bengal |
| DX DIAGNOSTIC TECH LLP |
Active
|
15,000.0 | 1 | Maharashtra |
| TEEN INVESTMENT ADVISORS LLP |
Active
|
450.2 Cr | 1 | Maharashtra |
| O3 CAPITAL GLOBAL ADVISORY PRIVATE LIMITED |
Active
|
74.6 L | 1 | Karnataka |
| BAAZAR RETAIL LIMITED |
Amalgamated
|
4.1 Cr | 1 | West Bengal |
| CONCORD ENVIRO SYSTEMS LIMITED |
Active
|
9.1 Cr | 1 | Maharashtra |
| CILICANT PRIVATE LIMITED |
Active
|
73.9 L | 1 | Maharashtra |
| BAAZAR RETAIL PRIVATE LIMITED |
Active
|
686.4 Cr | 1 | West Bengal |
| ELEMENTS AKADEMIA PRIVATE LIMITED. |
Strike Off
|
13.0 L | 1 | Delhi |
| KARMIC CLINICAL ACADEMY PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| ATLANTIC LIFE CARE PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| ZAVI DESIGNS PRIVATE LIMITED |
Active
|
5.0 Cr | 1 | Maharashtra |
| Callisto Brands LLP |
Active
|
10,000.0 | 1 | Maharashtra |
| LAPETUS REALTY LLP |
Active
|
1.0 L | 1 | Maharashtra |
| SONNET CAPITAL ADVISORS LLP |
Active
|
1.0 L | 1 | Maharashtra |
| TAGLR TECHNOLOGIES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| CARE DATA INFOMATICS PRIVATE LIMITED | Tamil Nadu | 2016 | ₹ 1.0 Cr |
| Erba Diagnostics Mannheim GmbH | Germany | - | - |
| Erba Diagnostics Holdings Limited | Ireland | - | - |
| Erba Lachema s.r.o. | Czech Republic | - | - |
| Erba Diagnostik Sanayi Ve Ticaret A. S | Turkey | - | - |
| Erba Diagnostics France SARL | France | - | - |
| Erba RUS ZAO | Russia | - | - |
| Erba Polska Sp. Z.o.o. | Poland | - | - |
| Immunovision Inc. | United States | - | - |
| Erba Diagnostics UK Ltd. | United Kingdom | - | - |
| Lumora Ltd. | United Kingdom | - | - |
| Erba USA Inc. | United States | - | - |
| Erba Diagnostics Limited | Ireland | - | - |
| Erba Corporate Services Limited | Uk | - | - |
| Calbiotech Inc | United States | - | - |
| Calbiotech Veterinary Diagnostics Inc | United States | - | - |
| Moduline System | United States | - | - |
| Erba Diagnostics Ukraine LLC | Ukarin | - | - |
| Erba Diagnostics Brazil | Brazil | - | - |
| Erba Diagnostics SRL | Romania | - | - |
| Erba Technologies Austria GmbH | Austria | - | - |
| Erba Diagnostics DMCC | United Arab Emirates | - | - |
| Erba Czech SRO | Czech Republic | - | - |
| TRANSASIA DIAGNOSTICS PRIVATE LIMITED | Maharashtra | 2020 | ₹ 25.0 Cr |
| Erba USA Inc | United States | - | - |
| Moduline system | United States | - | - |
| Immunovision Inc. | United States | - | - |
The incorporation date of TRANSASIA BIO-MEDICALS LIMITED is 10 May, 1985
The authorized share capital of TRANSASIA BIO-MEDICALS LIMITED is INR ₹ 4.4 Cr.
The paid-up capital of TRANSASIA BIO-MEDICALS LIMITED is INR ₹ 4.0 Cr.
The registered address of TRANSASIA BIO-MEDICALS LIMITED is TRANSASIA HOUSE, 8, CHANDIVALI STUDIO ROAD, NA MUMBAI Maharashtra - 400072
The CIN number of TRANSASIA BIO-MEDICALS LIMITED is U33110MH1985PLC036198.
Expand
Delete
Collapse
See
details
It will take sometime. Please come back in 10
minutes
